• High-Quality Products for Wholesalers & Distributors
  • Address
  • 35 Constitution Dr. Suite 1D, Bedford, NH 03110
  • Phone Number
  • (603) 471-1499

OmniTrust #212 Series Nitrile Powder Free Examination Glove

OmniTrust #212 Series Nitrile Powder Free Examination Glove – Chemo Rated
OmniTrust #212 Series Nitrile Powder Free Examination Glove – Chemo Rated

OmniTrust #212 Series Nitrile Powder Free Examination Glove – Chemo Rated

Our OmniTrust Nitrile Powder Free #212 Examination Glove is a thermally activated glove that starts conforming to your hand when donned. You will find our comfort formulation very comfortable, reducing hand fatigue.

Our OmniTrust Nitrile Powder Free #212 Examination Glove has our famous micro-texture fingertips and matte finish for added grip control without loss of tactile sensitivity. The #212 series is also tested for safe use with chemotherapy drugs.

Features/Benefits:

  • Comfortable Formulation & Thermally Activated to Reduce Hand Fatigue
  • Completely Latex FREE (No Risk for Latex Allergy)
  • Tested for Safe Use with Chemo Drugs
  • Micro-Textured for Superior Grip Control
  • Ambidextrous Beaded Cuff, Single Use Only

Industries:

  • Healthcare
  • Safety
  • Industrial
  • Dental
Order # Size Gloves/Box* Boxes/Case
212-21 S 100 10
212-22 M 100 10
212-23 L 100 10
212-24 XL 100 10

*Packaged by Weight

Powder Free Nitrile Examination Gloves

Not Made with Natural Rubber Latex

Non-Sterile / Finger Textured

Tested for use with Chemotherapy Drugs using ASTM D6978-05

  • Gloves used for protection against chemotherapy drug exposure should be selected specifically for the type of drugs being used.
  • Users are advised to review Material Safety Data Sheets to determine the required level of protection.

Low Dermatitis Potential

This product demonstrated reduced potential for sensitizing users to chemical additives

Warning:

Do not use this product if you have a known allergy to chemical additives

Not recommended for use with Carmustine and Thiotepa

Chemotherapy Drug/Concentration 

Médicaments de Chimiothérapie/Concentration

Minimum Breakthrough Detection (Minutes)/

Temps Minimal Avant de Perforer (Minutes)

Carmustine(BCNU)(3.3 mg/ml)3,300ppm 26.2(DO NOT USE)
Cisplatin(1.0 mg/ml) 1000ppm >240
Cyclophosphamide (Cytoxan) (20.0 mg/ml} 20,000ppm >240
Cytarabine {100 mg/ml) 100,000ppm >240
Dacarbazine (DTIC) (10.0 mg/ml) 10,000ppm >240
Doxorublcln Hydrochloride (2.0 mg/ml) 2,000ppm >240
Etoposide (20.0 mg/ml) 20,000ppm >240
Fluorouracil (50.0 mg/ml) 50,000ppm >240
Ifosfamide (50.0 mg/ml) 50,000ppm >240
Methotrexate {25.0 mg/ml) 25,000ppm >240
Mitomycin C {0.5 mg/ml) 500ppm >240
Mitoxantrone {2.0 mg/ml) 2,000ppm >240
Paclitaxel (Taxol) (6.0 mg/ml) 6,000ppm >240
Thioptepa (10.0 mg/ml) 10,000ppm 59.1(DO NOT USE)
Vincristine Sulfate (1.0 mg/ml) 1,000ppm >240
Fentanyl Citrate and Concentration

citrare de fentanyl et concentration

Minimum Breakthrough Detection Time (Minutes)

Temps minimal avant de perforer (minutes)

Fentanyl Citrate Injection (100mcg/2ml) >240

Related Products